A Study to Analyze The Impact of Pharmacist Consultation in Patients Beginning Intravenous Cancer Treatment
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- La Crosse, Wisconsin: 18-010611
Sponsor Protocol Number: 18-010611
About this study
The purpose of this study is to assess the impact of pharmacist consultation in patients receiving first dose, first cycle intravenous cancer treatment on patient understanding of the cancer treatment, adverse drug events, and adherence. Additionally, this study will report the frequency of healthcare utilization for side effect management.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- ≥ 18 years of age.
- Patients receiving first dose, first cycle cancer treatment within the clinic.
- Receiving treatment for cancer within the Mayo Clinic Health System in Wisconsin at Barron, Eau Claire, La Crosse, or Menomonie, Wisconsin.
- Patient must be naïve to injectable chemotherapy.
- Accepting intervention with oral consent.
Exclusion Criteria:
- < 18 years of age.
- Patients receiving non first cycle cancer treatment.
- Refusal of pharmacist consultation.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
La Crosse, Wis.
Mayo Clinic principal investigator Travis Dash, Pharm.D., R.Ph. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available